Recent Analysts’ Ratings Updates for Neurocrine Biosciences (NBIX)
A number of research firms have changed their ratings and price targets for Neurocrine Biosciences (NASDAQ: NBIX): 12/23/2024 – Neurocrine Biosciences had its “overweight” rating...
Publicity top